Cavitation Technologies Replaces Buyer, Raises Deal Value to $42M
CVAT sits 39% above its 52-week low of $0.022.
Summary
Cavitation Technologies has signed new definitive purchase agreements with BrightFlixx Finance (Luxembourg) S.A. for cash tender offers totaling $42 million — $35 million for CVAT and $7 million for Alchemy Beverages, in which CVAT holds a 17% stake. The new agreements replace the prior $35 million deal with European Guarantee Services, which has been terminated. Financing remains with the same institution, Bright Wealth Banking, and terms are substantially similar. This follows the August 17 announcement of the original EGS deal and the October 6 10-K showing only $3,000 in revenue and a going concern warning. The higher aggregate consideration and new counterparty are material developments for a company with a market cap under $10 million. Tender offers have not yet commenced; BrightFlixx expects to file Schedule TO documents with the SEC.
At the time of this announcement, CVAT was trading at $0.03 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9.7M. The 52-week trading range was $0.02 to $0.11. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.